Bob Lechleider
Chief Tech/Sci/R&D Officer at IMMUNOME, INC.
Profile
Bob Lechleider is currently the Chief Medical Officer at Immunome, Inc. He previously worked as the Senior Vice President-Clinical Development at Seagen Inc. and as the Chief Medical Officer at OncoResponse, Inc. from 2020 to 2023.
Dr. Lechleider completed his undergraduate degree at Princeton University and obtained a doctorate from the University of Illinois College of Medicine.
Bob Lechleider active positions
Companies | Position | Start |
---|---|---|
IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 2023-10-18 |
Former positions of Bob Lechleider
Companies | Position | End |
---|---|---|
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 2023-09-30 |
SEAGEN INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Training of Bob Lechleider
Princeton University | Undergraduate Degree |
University of Illinois College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IMMUNOME, INC. | Health Technology |
Private companies | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Bob Lechleider